| Financial Year |
March 31 2023 |
| Monetary Funds |
157,811,262.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,698,164.32 |
| Accounts Receivable |
113,080,127.57 |
| Advances to Suppliers |
4,204,372.06 |
| Other Receivables |
3,048,627.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
115,473,107.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
643,385.11 |
| Total Current Assets |
446,649,974.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,423,457.48 |
| Investment Properties |
-- |
| Fixed Assetes |
198,799,926.12 |
| Under-construction Projects |
227,267.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,423,921.43 |
| R&D expenses |
-- |
| Goodwill |
2,680,605.26 |
| Long-Term Deferred and Prepaid Expenses |
1,090,801.89 |
| Deferred Income Tax Assets |
4,227,892.12 |
| Other Non-Current Assets |
3,695,037.91 |
| Sub-Total of Non-Current Assets |
248,120,167.54 |
| Total Assets |
694,770,142.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
20,852,180.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,489,782.48 |
| Taxes Payable |
9,452,519.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,327,329.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
811,792.28 |
| Sub-Total of Current Liabilities |
109,869,737.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
18,700,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,866,113.82 |
| Total Liabilities |
139,735,851.28 |
| Paid-In Capital(Or Share Stock) |
192,192,000.00 |
| Capital Surplus |
92,217,668.78 |
| Surplus Reserve |
39,781,485.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
216,534,715.10 |
| Minority Stockholder's Interest |
1,747,226.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
553,287,064.26 |
| Owner's Equity（Stockholder's Equity） |
555,034,290.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
694,770,142.17 |
